User menu

A phase IB, open-label, parallel design study of PTK787/ZK 222584 in combination with irinotecan in patients (Pts) with metastatic colorectal cancer (CRC) to investigate the interaction between the agents.

Bibliographic reference Teipar, S ; Humblet, Yves ; Lin, E ; Bono, P ; Jalava, T ; et. al. A phase IB, open-label, parallel design study of PTK787/ZK 222584 in combination with irinotecan in patients (Pts) with metastatic colorectal cancer (CRC) to investigate the interaction between the agents..41st Annual Meeting of the American-Society-of-Clinical-Oncology (Orlando (Fl), May 13-17, 2005). In: Journal of Clinical Oncology, Vol. 23, no. 16, p. 269S-269S (2005)
Permanent URL http://hdl.handle.net/2078.1/60905